These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17563921)

  • 1. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.
    Gómez-Gil E; Navinés R; Martínez De Osaba MJ; Díaz-Ricart M; Escolar G; Salamero M; Martín-Santos R; Galán A; Gastó C
    Psychoneuroendocrinology; 2010 May; 35(4):481-9. PubMed ID: 19762159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior.
    Pitchot W; Hansenne M; Pinto E; Reggers J; Fuchs S; Ansseau M
    Biol Psychiatry; 2005 Dec; 58(11):854-8. PubMed ID: 16139805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone.
    McAllister-Williams RH; Alhaj HA; Massey A; Pankiv J; Reckermann U
    Psychol Med; 2014 Mar; 44(4):767-77. PubMed ID: 23809646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the 5-HT1A agonist action of buspirone in man.
    Bridge MW; Marvin G; Thompson CE; Sharma A; Jones DA; Kendall MJ
    Psychopharmacology (Berl); 2001 Nov; 158(3):224-9. PubMed ID: 11713611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep.
    Broadbear JH; Pierce BN; Clarke IJ; Canny BJ
    J Neuroendocrinol; 2005 Dec; 17(12):804-10. PubMed ID: 16280027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H; Skelin I; Debonnel G; Diksic M
    Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
    Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
    Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.
    McAllister-Williams RH; Massey AE; Fairchild G
    J Psychopharmacol; 2007 Nov; 21(8):826-32. PubMed ID: 17715208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.
    Porter RJ; Gallagher P; Watson S; Lunn BS; Young AH
    Psychopharmacology (Berl); 2002 Aug; 163(1):68-75. PubMed ID: 12185402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients.
    González A; Fazzino F; Castillo M; Mata S; Lima L
    Neuroimmunomodulation; 2007; 14(1):8-15. PubMed ID: 17700035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.